SCHEMBL5777821

SCHEMBL5777821

N/N=C(/c1ccc(-c2cnco2)cc1)c1ccc(O)c(C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 3/20 0.42
PKM P14618 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
MYC P01106 1/20 0.40
CDK1 P06493 3/20 0.38
CDK2 P24941 3/20 0.38
CCNA2 P20248 1/20 0.38
LCK P06239 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
NOTUM Q6P988 1/20 0.38
GAA P10253 1/20 0.38
APP P05067 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775952 0.85 NPC1 (0.49) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL5776483 0.78 CDK1 (0.49) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL5777062 0.77 NPC1 (0.44) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL5779456 0.76 GPR119 (0.45) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL1010247 0.73 PKM (0.59) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL5777825 0.71 NPC1 (0.45) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL1010203 0.69 MYC (0.62) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL15507354 0.66 KDM4E (0.57) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL2422300 0.66 NOTUM (0.59) NPC1KDM4EPKMRAB9AALDH1A1
SCHEMBL2431912 0.66 PKM (0.59) NPC1KDM4EPKMRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT NPC1 952/4885KDM4E 4325/4885PKM 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.